Description
Amikacin 500mg Injection is a broad-spectrum aminoglycoside antibiotic used to treat severe bacterial infections, including respiratory tract infections, urinary tract infections (UTIs), skin infections, bone and joint infections, intra-abdominal infections, and septicemia. It works by inhibiting bacterial protein synthesis, effectively stopping bacterial growth. This injection is commonly used in hospital settings for serious infections caused by gram-negative bacteria.
Benefits
- Highly Effective Against Resistant Bacterial Infections.
- Used for Severe Respiratory, Urinary, and Bone Infections.
- Rapid Onset of Action When Given via IV or IM.
- Essential for Treating Life-Threatening Infections in Hospitalized Patients.
Administration & Dosage
- Administered by a Healthcare Professional Only.
- Given as an Intramuscular (IM) or Intravenous (IV) Injection.
- Dosage:
- Adults: 500mg once every 12 hours (or as prescribed by the doctor).
- Children: Dose adjusted based on weight and severity of infection.
- Do Not Self-Administer.
Side Effects
Some patients may experience:
- Nausea, Vomiting, or Diarrhea.
- Pain, Swelling, or Redness at the Injection Site.
- Hearing Loss or Ringing in the Ears (Ototoxicity).
- Kidney Dysfunction (Nephrotoxicity).
- Muscle Weakness or Nerve Damage (Neurotoxicity in Rare Cases).
Seek immediate medical attention if serious side effects occur.
Precautions
- Not Recommended for Patients Allergic to Aminoglycosides.
- Use with Caution in Patients with Kidney Disease or Hearing Impairment.
- Regular Monitoring of Kidney Function and Hearing is Advised.
- May Cause Muscle Weakness in Patients with Neuromuscular Disorders.
- Store in a Cool, Dry Place Away from Direct Sunlight.
- Keep Out of Reach of Children.
Disclaimer:
This information is for educational purposes only and should not be considered medical advice. Always consult a doctor before using this medication. The manufacturer or supplier is not responsible for any misuse or adverse effects.
Reviews
There are no reviews yet.